Modulation of NMDA-mediated excitotoxicity by protein kinase C
1Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Abstract:
Excessive activation of N-methyl-D-aspartate (NMDA) receptors leads to cell death in human embryonic kidney-293 (HEK) cells which have been transfected with recombinant NMDA receptors. To evaluate the role of protein kinase C (PKC) activation in NMDA-mediated toxicity, we have analyzed the survival of transfected HEK cells using trypan blue exclusion. We found that NMDA-mediated death of HEK cells transfected with NR1/NR2A subunits was increased by exposure to phorbol esters and reduced by inhibitors of PKC activation, or PKC down-regulation. The region of NR2A that provides the PKC-induced enhancement of cell death was localized to a discrete segment of the C-terminus. Use of isoform-specific PKC inhibitors showed that Ca(2+)- and lipid-dependent PKC isoforms (cPKCs), specifically PKCbeta1, was responsible for the increase in cell death when phorbol esters were applied prior to NMDA in these cells. PKC activity measured by an in vitro kinase assay was also increased in NR1A/NR2A-transfected HEK cells following NMDA stimulation. These results suggest that PKC acts on the C-terminus of NR2A to accentuate cell death in NR1/NR2A-transfected cells and demonstrate that this effect is mediated by cPKC isoforms. These data indicate that elevation of cellular PKC activity can increase neurotoxicity mediated by NMDA receptor activation.
Insights
Protein kinase C (PKC) activation enhances N-methyl-D-aspartate (NMDA) receptor-mediated cell death in human embryonic kidney cells. This neurotoxicity is specifically mediated by classical PKC isoforms, particularly PKCbeta1.
Area of Science:
- Neuroscience
- Molecular Biology
- Cell Biology
Background:
- Excessive N-methyl-D-aspartate (NMDA) receptor activation causes cell death.
- Protein kinase C (PKC) is implicated in cellular signaling pathways.
Purpose of the Study:
- To investigate the role of PKC activation in NMDA receptor-mediated toxicity.
- To identify the specific PKC isoforms involved in this process.
Main Methods:
- Utilized human embryonic kidney-293 (HEK) cells transfected with NMDA receptor subunits (NR1/NR2A).
- Assessed cell survival using trypan blue exclusion assay.
- Employed phorbol esters, PKC inhibitors, and isoform-specific inhibitors.
- Measured PKC activity via in vitro kinase assay.
Main Results:
- NMDA-induced HEK cell death was potentiated by phorbol ester exposure.
- PKC activation inhibitors or down-regulation reduced NMDA-mediated toxicity.
- The C-terminus of the NR2A subunit was identified as crucial for PKC-induced enhancement of cell death.
- Classical PKC isoforms (cPKCs), especially PKCbeta1, mediated the increased cell death.
- NMDA stimulation increased PKC activity in transfected cells.
Conclusions:
- PKC activation, particularly via cPKC isoforms like PKCbeta1, accentuates NMDA receptor-mediated neurotoxicity.
- PKC acts on the NR2A C-terminus to increase cell death.
- Elevated cellular PKC activity can exacerbate NMDA receptor-induced neurotoxicity.
Related Concept Videos
Long-term Potentiation
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
MAPK Signaling Cascades
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Ligand-Gated Ion Channel Receptor: Gating Mechanism


